Sign Out
Breast cancer: Capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Capecitabine is also indicated as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
Colon, colorectal cancer: Capecitabine is indicated for the adjuvant treatment of patients with colon cancer.
Capecitabine is indicated for the treatment of patients with metastatic colorectal cancer.
Oesophagogastric cancer: Capecitabine is indicated for first-line treatment of patients with advanced Oesophagogastric cancer.
Continue with Google